Organogenesis Holdings Inc.
ORGOFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Organogenesis Holdings Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 9 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Apr 24, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| OSAIC HOLDINGS, INC. | 2026-03-31 | 7,528 | $17.8K | SEC filing |
| Advisory Services Network, LLC | 2026-03-31 | 286 | $678 | SEC filing |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2026-03-31 | 879,832 | $2.09M | SEC filing |
| HSBC HOLDINGS PLC | 2026-03-31 | 51,963 | $122K | SEC filing |
| ACADIAN ASSET MANAGEMENT LLC | 2026-03-31 | 1,576,645 | Not shown | SEC filing |
| Metis Global Partners, LLC | 2026-03-31 | 17,237 | $40.9K | SEC filing |
| GSA CAPITAL PARTNERS LLP | 2026-03-31 | 155,869 | Not shown | SEC filing |
| STRS OHIO | 2026-03-31 | 24,400 | $57.8K | SEC filing |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2026-03-31 | 42,152 | Not shown | SEC filing |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 2026-03-31 | 20,673 | $49K | SEC filing |
| SEI INVESTMENTS CO | 2026-03-31 | 40,244 | $95.4K | SEC filing |
| SPHERA FUNDS MANAGEMENT LTD. | 2026-03-31 | 550,000 | $1.3M | SEC filing |
| JPMORGAN CHASE & CO | 2026-03-31 | 27,989 | $64.1K | SEC filing |
| Essential Partners LLC | 2026-03-31 | 524 | $1.24K | SEC filing |
| FMR LLC | 2026-03-31 | 375,815 | $891K | SEC filing |
| Farther Finance Advisors, LLC | 2026-03-31 | 57,415 | $133K | SEC filing |
| INTECH INVESTMENT MANAGEMENT LLC | 2026-03-31 | 18,024 | $42.7K | SEC filing |
| Aquatic Capital Management LLC | 2026-03-31 | 16,089 | $38.1K | SEC filing |
| RHUMBLINE ADVISERS | 2026-03-31 | 80,015 | $190K | SEC filing |
| US BANCORP \DE\ | 2026-03-31 | 76 | $180 | SEC filing |
- Each value is checked against Organogenesis Holdings Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 3 rows: the filed value is about 1,000 times too small for the share count at Organogenesis Holdings Inc.'s share price.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- Pallas Capital Advisors LLC: 19,713 shares reported 2025-12-31; 18,685 shares reported 2026-03-31.
- WEALTH ENHANCEMENT ADVISORY SERVICES, LLC: 35,544 shares reported 2025-12-31; 49,721 shares reported 2026-03-31.
- Legal & General Group Plc: 7,141 shares reported 2025-12-31; 6,087 shares reported 2026-03-31.
114 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Organogenesis Holdings Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-12-16 · NUSSDORF GLENN H: Larger than all 19 other insider sales of Class A Common Stock on file. SEC filing
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-09 | Driscoll Michael Joseph · Director | Class A Common Stock | P — Open market or private purchase | +10,000 | 2.67 | SEC filing |
| 2026-03-09 | Leibowitz Arthur S · Director | Class A Common Stock | P — Open market or private purchase | +5,000 | 2.68 | SEC filing |
| 2025-12-16 | NUSSDORF GLENN H · Director | Class A Common Stock | S — Open market or private sale | −200,000 | 5.14 | SEC filing |
| 2025-11-26 | NUSSDORF GLENN H · Director, 10% owner | Class A Common Stock | S — Open market or private sale | −187,957 | 5.29 | SEC filing |
| 2025-11-25 | NUSSDORF GLENN H · Director, 10% owner | Class A Common Stock | S — Open market or private sale | −12,043 | 5.30 | SEC filing |
| 2025-11-24 | NUSSDORF GLENN H · Director, 10% owner | Class A Common Stock | S — Open market or private sale | −100,000 | 5.34 | SEC filing |
| 2025-06-10 | NUSSDORF GLENN H · Director, 10% owner | Class A Common Stock | S — Open market or private sale | −18,620 | 3.56 | SEC filing |
| 2025-06-09 | NUSSDORF GLENN H · Director, 10% owner | Class A Common Stock | S — Open market or private sale | −4,156 | 3.50 | SEC filing |
Showing 8 of 17 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-03-01 | Cavorsi Robert · Vice President, Strategy | Class A Common Stock | F — Payment of exercise price or tax by delivering securities | −700 | SEC filing |
| 2026-02-18 | Quintero Gilberto · Director | Class A Common Stock | A — Grant, award, or other acquisition | +48,828 | SEC filing |
| 2026-02-18 | Lustig Garrett · Director | Class A Common Stock | A — Grant, award, or other acquisition | +48,828 | SEC filing |
| 2026-02-18 | Francisco David · Chief Financial Officer | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +111,358 | SEC filing |
| 2026-02-18 | Montecalvo Antonio S. · Vice President, Health Policy | Class A Common Stock | A — Grant, award, or other acquisition | +40,625 | SEC filing |
| 2026-02-18 | Cavorsi Robert · Vice President, Strategy | Class A Common Stock | A — Grant, award, or other acquisition | +93,750 | SEC filing |
| 2026-02-18 | Bilbo Patrick · Chief Operating Officer | Class A Common Stock | A — Grant, award, or other acquisition | +210,937 | SEC filing |
| 2026-02-18 | Francisco David · Chief Financial Officer | Class A Common Stock | A — Grant, award, or other acquisition | +195,312 | SEC filing |
Showing 8 of 38 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2024-11-27 | GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · 10% owner | Class A Common Stock | D — Disposition to the issuer | −500,000 | SEC filing |
| 2024-11-27 | NUSSDORF GLENN H · Director, 10% owner | Class A Common Stock | D — Disposition to the issuer | −500,000 | SEC filing |
| 2024-11-12 | NUSSDORF GLENN H · Director, 10% owner | Class A Common Stock | J — Other acquisition or disposition | −590,332 | SEC filing |
| 2024-11-12 | NUSSDORF GLENN H · Director, 10% owner | Class A Common Stock | J — Other acquisition or disposition | −224,668 | SEC filing |
| 2024-11-12 | NUSSDORF GLENN H · Director, 10% owner | Class A Common Stock | D — Disposition to the issuer | −294,000 | SEC filing |
| 2024-11-12 | NUSSDORF GLENN H · Director, 10% owner | Class A Common Stock | D — Disposition to the issuer | −2,550,822 | SEC filing |
| 2024-11-12 | NUSSDORF GLENN H · Director, 10% owner | Class A Common Stock | D — Disposition to the issuer | −3,761,909 | SEC filing |
Showing 7 of 7 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.